Validation of the Turkish Translation of the London Speech Evaluation Scale

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Status: Completed

Conditions: Speech Intelligibility; Speech Dysfunction; Speech Disorders; Speech; Head and Neck Cancer

Treatments: Other: The speech records related to the reading document

Study type: Observational

Funder types: Other

Identifiers

NCT04690166

462 (Other Grant/Funding Number)

Details and patient eligibility

About

Purpose of the study is the validation and cultual adaptation of the Turkish translation of the London Speech Evaluation Scale (LSE-T), so that it would be used as an assessment tool for Turkish head and neck cancer patients. There is no validated Turkish version of LSE to measure severity of perceptual speech in head and neck cancer patients.

Full description

The speech function is a multidirectional process that depends on complex neuro-muscular network. The function can be evaluated using instrumental, such as voice analysis computer programmes, scales, or well structured questionnaires. There are many scales for assessment of perceptual speech but there is no validated for head and neck patients. The study will assess the construct validity and adaptation of the Turkish translation of Speech Specific Perceptual Speech Evaluation as known as London Speech Evaluation Scale. The investigators developed the Turkish translation of this scale (LSE-T), according to the cross-cultural adaptation guidelines. Two translators translated the LSE into Turkish and a native English language speaker reverse-translated it into English. The back translation was sent to the original author for proofreading. The LSE scale consisted of 6 parameters and 4 scores related with perceptual speech in head and neck cancer patients.

Enrollment: 120 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Able to speak, read, understand and write in Turkish
• History of oral, orofarengeal cancer
• Volunteers who accept the informed consent

Exclusion criteria

• Mental disorders
• Cognitive limitations
• Able not to speak, read, understand and write in Turkish
• Underwent any surgery last six month
• Permanent tracheostomy, total laryngectomy
• Pregnancy
• Out of age 18-70 years old
• Adults who do not accept the informed consent.

Trial design

120 participants in 2 patient groups

Cancer Patients

Description:

In outpatients clinic, the first group consists of 60 head and neck cancer patients who were treated by ours. The participants will given the document consists that "bit, bet, but" words and also a brief part of "Diyet passage" who written by Omer Seyffettin. The speech record of patients who read to document, will evaluated by three judges (otorhinolaryngologist). Three judges will scoring to Turkish translation of London Speech Evaluation Scale (LSE-T), consists of 6 parameters. After the six weeks, the records were scored again as randomisely.

Treatment:

Other: The speech records related to the reading document

Healty Control

Description:

In outpatients clinic, the control group consists of 60 patients who have not speech and hear impairments. The participants will given the document consists that "bit, bet, but" words and also a brief part of "Diyet passage" who written by Omer Seyffettin. The speech record of patients who read to document, will evaluated by three judges (otorhinolaryngologist). Three judges will scoring to Turkish translation of London Speech Evaluation Scale (LSE-T), consists of 6 parameters. After the six weeks, the records were scored again as randomisely.

Treatment:

Other: The speech records related to the reading document